Artes also will be responsible for the 100 L scale production of a Minapharm protein based on an existing process using E. coli. Minapharm will carry out the pertinent process R&D, production, and ...

MOSCOW, CAIRO and BERLIN, April 22, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), Egypt's Minapharm, the regional leader in recombinant DNA ...

ARTES Biotechnology and Rhein Minapharm Biogenetics, a subsidiary of Minapharm SAE have jointly announced the start of a strategic collaboration to develop three therapeutic proteins. Financial ...